87407-3
Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay
Active
Term Description
This term was created for, but not limited in use to, the submitter's Theradiag Lisa-Tracker Golimumab and anti-Golimumab test kits.
Part Description
LP250855-6 Golimumab
Golimumab (GLM) is a fully human monoclonal antibody that binds with tumor necrosis factor alpha (TNF-α) and is used to treat patients with severe to moderate active rheumatoid arthritis, patients with active and progressive psoriatic arthritis alone or with methotrexate, and patients with active ankylosing spondylitis whose response to other therapies has been insufficient. TNFα is a pro-inflammatory cytokine that produces fever, inflammation, tissue destruction, and possibly shock and death. GLM differs from other TNF-α inhibitors in that it combines with both the transmembrane and soluble forms of TNF-α. GLM is administered once a month compared to the other TNF-α inhibitors that require dosing twice a week or every two weeks. The safety of using GLM is comparable to other TNF-α inhibitors which as a class have an increased risk of opportunistic infections, lymphoma and reactivation of latent tuberculosis. PMID: 20694072 PMID: 10936147 PMID: 20200692
Source: Regenstrief LOINC
LOINC Names Get Info
- Fully-Specified Name
- Golimumab Ab:
MCnc: Pt: Ser/Plas: Qn: IA - Long Common Name
- Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay
- Short Name
- Golimumab Ab SerPl IA-mCnc
- Display Name
- Golimumab Ab IA [Mass/Vol]
- Consumer Name Alpha Get Info
- Golimumab antibody, Blood
Part Model Get Info
- Component
- Golimumab Ab
LP250858-0
- Analyte
- Golimumab Ab
LP250858-0
- Component Numerator
- Golimumab Ab
LP250858-0
- Component Numerator Core
- Golimumab
LP250855-6
- Component Numerator Core Suffix
- Ab
LP20667-9
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- MCnc
LP6827-2
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Ser/Plas
LP7576-4
- System Core
- Ser/Plas
LP7576-4
- Super System
- NULL
- Scale
- Qn
LP7753-9
- Method
- IA
LP217197-5
Basic Attributes
- Class
- DRUG/TOX
- Type
- Laboratory
- First Released
- Version 2.63
- Last Updated
- Version 2.73 (MIN)
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 18102
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Golimumab Ab: |
| de-AT | German (Austria) | Synonyms: Golimumab Antikörper |
| el-GR | Greek (Greece) | Γολιμουμάμπη Αντίσωμα: Synonyms: DRUG/TOX IA MCnc Pt Qn Αντίσωμα Γολιμουμάμπη Ορός Ορός/Πλάσμα Πλάσμα |
| es-ES | Spanish (Spain) | Golimumab Anticuerpos: Synonyms: Cuantitativo |
| es-MX | Spanish (Mexico) | Golimumab Ab: |
| fr-FR | French (France) | Golimumab Ac: |
| it-IT | Italian (Italy) | Golimumab Ab: Synonyms: anticorpo Concentrazione di Massa Immunoassay Livelli farmacologici e tossicologia Plasma Punto nel tempo (episodio) Siero Siero o Plasma |
| nl-NL | Dutch (Netherlands) | golimumab As: Synonyms: antistof; |
| zh-CN | Chinese (China) | 戈利木单抗 抗体: Synonyms: Ab; |
Example Units
| Unit | Source |
|---|---|
| ng/mL | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://